Skip to main content
Back to companies
Bicara Therapeutics logo

Bicara Therapeutics

Biotech/PharmaBiopharmaBiotechnologyLife ScienceOncologyTherapeutics
Cambridge, Massachusetts, United StatesFounded 202058+ employeesBCAX
$463M raisedGrowth· last: post ipo equity (Feb 2026)· 4 rounds
Backed by(19 investors)
The Rise Fund · LeadBraidwell · LeadRA Capital Management · LeadBiocon · LeadRed Tree Venture Capital · LeadTPG · Lead+8 more

Bicara Therapeutics is a clinical-stage company developing first-in-class biologics engineered to bring together the precision of targeted therapy and the power of tumor modulators. The company's dual-action biologics are designed to deliver an immunomodulatory payload directly to the tumor microenvironment to ramp up immune cell activity, potentially offering long-lasting efficacy. For more, please visit: bicara.com.

Founders

Skip jobs list

Open Positions at Bicara Therapeutics (13 Jobs)

13 open · 3 remote · 1 filled

Showing 13 jobs